Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-α in SK-BR-3 breast cancer cells
Authors:
- Sonja M. SchneiderSSSonja M. Schneider
- Martin OffterdingerMOMartin Offterdinger
- Evelyn DittrichEDEvelyn Dittrich
- Barbara FazenyBFBarbara Fazeny
- Rudolf ValentaRVRudolf Valenta
- Heinz HuberHHHeinz Huber
- Christian DittrichCDChristian Dittrich
- Thomas W. GruntTGThomas W. Grunt
- 1 May 1997
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 115 (1) , 63-72
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cellsInternational Journal of Cancer, 1995
- Regulation of Interleukin-8 Gene Expression by All-trans Retinoic AcidBiochemical and Biophysical Research Communications, 1995
- A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signalingCell, 1994
- The Family of c-erbB Genes: From Basic Research to Clinical OncologyOncology Research and Treatment, 1994
- Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor functionMolecular and Cellular Endocrinology, 1993
- Differentiation of cultured human breast cancer cells (AU‐565 and MCF‐7) associated with loss of cell surface HER‐2/neu antigenMolecular Carcinogenesis, 1990
- p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.Molecular and Cellular Biology, 1989
- Overexpression of the c‐erbB‐2 protein in human breast tumor cell linesJournal of Cellular Biochemistry, 1989
- Effects of herbimycin derivatives on src oncogene function in relation to antitumor activity.The Journal of Antibiotics, 1988
- Does Vanadium Play a Role in Cellular Regulation?1981